Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mehmet Yumru

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Clinical Drug Investigation|June 12, 2008
Quetiapine and ziprasidone as adjuncts in treatment-resistant obsessive-compulsive disorder: a retrospective comparative studyHaluk A Savas, Mehmet Yumru, Murat E Ozen
Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 4, 2006
Acute dystonia after initial doses of ziprasidone: a case reportMehmet Yumru, Haluk A Savas, Salih Selek, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 24, 2007
Atypical antipsychotics as "mood stabilizers": a retrospective chart reviewHaluk A Savas, Mehmet Yumru, M Cemal Kaya, et al.
The Journal of ECT|December 20, 2007
Patients' and their relatives' attitudes toward electroconvulsive therapy in bipolar disorderOsman Virit, Duygu Ayar, Haluk Asuman Savas, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|March 17, 2007
Neuroleptic malignant syndrome induced by ziprasidone on the second day of treatmentMurat Eren Ozen, Mehmet Yumru, Haluk A Savas, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|June 17, 2009
Oxidative imbalance in bipolar disorder subtypes: a comparative studyMehmet Yumru, Haluk A Savas, Aysun Kalenderoglu, et al.
Journal of Affective Disorders|September 18, 2007
The course of nitric oxide and superoxide dismutase during treatment of bipolar depressive episodeSalih Selek, Haluk A Savas, H Serdar Gergerlioglu, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|February 17, 2007
Changes in nitric oxide level and superoxide dismutase activity during antimanic treatmentH Serdar Gergerlioglu, Haluk A Savas, Feridun Bulbul, et al.
Neuropsychobiology|September 25, 2009
A defect in the antioxidant defense system in schizophreniaOsman Virit, Abdurrahman Altindag, Mehmet Yumru, et al.
Neuropsychobiology|March 25, 2006
Atypical antipsychotic usage-related higher serum leptin levels and disabled lipid profiles in euthymic bipolar patientsH Serdar Gergerlioglu, Haluk A Savas, Ahmet Celik, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Clinical Drug Investigation|June 12, 2008
Quetiapine and ziprasidone as adjuncts in treatment-resistant obsessive-compulsive disorder: a retrospective comparative studyHaluk A Savas, Mehmet Yumru, Murat E Ozen
Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 4, 2006
Acute dystonia after initial doses of ziprasidone: a case reportMehmet Yumru, Haluk A Savas, Salih Selek, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 24, 2007
Atypical antipsychotics as "mood stabilizers": a retrospective chart reviewHaluk A Savas, Mehmet Yumru, M Cemal Kaya, et al.
The Journal of ECT|December 20, 2007
Patients' and their relatives' attitudes toward electroconvulsive therapy in bipolar disorderOsman Virit, Duygu Ayar, Haluk Asuman Savas, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|March 17, 2007
Neuroleptic malignant syndrome induced by ziprasidone on the second day of treatmentMurat Eren Ozen, Mehmet Yumru, Haluk A Savas, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|June 17, 2009
Oxidative imbalance in bipolar disorder subtypes: a comparative studyMehmet Yumru, Haluk A Savas, Aysun Kalenderoglu, et al.
Journal of Affective Disorders|September 18, 2007
The course of nitric oxide and superoxide dismutase during treatment of bipolar depressive episodeSalih Selek, Haluk A Savas, H Serdar Gergerlioglu, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|February 17, 2007
Changes in nitric oxide level and superoxide dismutase activity during antimanic treatmentH Serdar Gergerlioglu, Haluk A Savas, Feridun Bulbul, et al.
Neuropsychobiology|September 25, 2009
A defect in the antioxidant defense system in schizophreniaOsman Virit, Abdurrahman Altindag, Mehmet Yumru, et al.
Neuropsychobiology|March 25, 2006
Atypical antipsychotic usage-related higher serum leptin levels and disabled lipid profiles in euthymic bipolar patientsH Serdar Gergerlioglu, Haluk A Savas, Ahmet Celik, et al.
Pageof 2